Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor α chain-deficient mice

Clinical and Experimental Allergy

Volumn 30, Issue 6, 2000, Pages 874-881

  Tanaka, H ^a   Kawada, N ^a   Yamada, T ^a   Kawada, K ^b   Takatsu, K ^c   Nagai, H ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Gifu College of Medical Technology   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bronchial hyperresponsiveness; Eosinophils; IL 5 receptor chain; Mice

Indexed keywords

ACETYLCHOLINE; ALLERGEN; ANTIGEN; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; EOSINOPHILIA; HISTOPATHOLOGY; LUNG; LUNG LAVAGE; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

ACETYLCHOLINE; ALLERGENS; ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; IMMUNOGLOBULIN E; INFLAMMATION; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5;

EID: 0034041358     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00828.x     Document Type: Article

References (31)

1. 1 Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy 1985; 15:411-8.
2. 2 Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J. Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in utopic asthma. N Engl J Med 1992; 326:298-304.
3. 3 Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ. Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87:1541-6.
4. 4 Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8:349-55.
5. 5 Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DG. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol 1992; 148:3820-9.
6. 6 Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J, Nakahata T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 1998; 91:187-95.
7. 7 Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236:944-7.
8. 8 Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K. Purified Interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988; 167:43-56.
9. 9 Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K, Suda T. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988; 167:1737-42.
10. 10 Lopez AF, Sanderson CJ, Gamble JR, Campbell HR, Young IG, Vadas MA. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-24.
11. 11 Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990; 85:422-36.
12. 12 Corry DB, Folkesson HG, Wamock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183:109-17.
13. 13 Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, Jones H, Watnick AS, Egan RW, Kreutner W, Adams GK III. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993; 148: 1623-7.
14. 14 Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK, IIIKreutner W, Egan RW, Chapman RW. Effect of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995; 152:467-72.
15. 15 Nagai H, Yamaguchi S, Inagaki N, Tsuruoka N, Yasumichi H, Takatsu K. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci 1993; 53:PL243-7.
16. 16 Nagai H, Yamaguchi S, Maeda Y, Tanaka H. Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice. Clin Exp Allergy 1996; 26:642-7.
17. 17 Van Oosterhout AJM, Ladenius ARC, Savelkoul HFJ, Van Ark I, Delsman KC, Nijkamp FP. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993; 147:548-52.
18. 18 Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, Brenneise IE, Horton MA, Haczku A, Gelfand EW, Leikauf GD, Lee NA. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997; 185:2143-56.
19. 19 Lefort J, Bachelet CM, Leduc D, Vargaftig BB. Effect of antigen provocation of IL-5 transgenic mice on eosinophil mobilization and bronchial hyperresponsiveness. J Allergy Clin Immunol 1996; 97:788-99.
20. 20 Iwamoto T, Takatsu K. Evaluation of airway hyperreactivity in interleukin-5 transgenic mice. Int Arch Allergy Immunol 1995; 108 (Suppl. 1):28-30.
21. 21 Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183:195-201.
22. 22 Iwama T, Nagai H, Tsuruoka N, Koda A. Effect of murine recombinant interleukin-5 on bronchial reactivity in guinea-pigs. Clin Exp Allergy 1993; 23:32-8.
23. 23 Takatsu K. Interleukin-5. Curr Opin Immunol 1992; 4:299-306.
24. 24 Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A, Takatsu K. Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med 1992; 175:341-51.
25. 25 Yoshida T, Ikuta K, Sugaya H, Maki K, Takagi M, Kanazawa H, et al. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonesis in IL-5Rα-deficient mice. Immunity 1996; 4:483-94.
26. 26 Nagai H, Maeda Y, Tanaka H. The effect of anti-IL-4 monoclonal antibody, rapamycin and interferon-γ on airway hyperreactivity to acetylcholine in mice. Clin Exp Allergy 1997; 27:218-24.
27. 27 Tanaka H, Nagai H, Maeda Y. Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice. Life Sci 1998;62:PL169-74.
28. 28 Yamaguchi S, Nagai H, Tanaka H, Tsujimoto M, Tsuruoka N. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci 1994; 54:PL471-5.
29. 29 Hogan SP, Koskinen A, Foster PS. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol 1997; 75:284-8.
30. 30 De Sanctis GT, Drazen JM. Genetics of native airway responsiveness in mice. Am J Respir Crit Care Med 1997; 156:582-8.
31. 31 Péne J, Rousset F, Briere F, Chretien I, Wideman J, Bonnefoy JY, DeVies IE. Interleukin 5 enhances interleukin-4-induced IgE production by normal human B cells. Eur J Immunol 1988; 18:929-35.